Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

Voriconazole Pharmacokinetics Administered at 4 mg/kg IM and IV in Nursehound Sharks (Scyliorhinus stellaris) Under Human Care
Daniela Cañizares-Cooz, Daniel García‐Párraga, Sonia Rubio Langre, et al.
Veterinary Sciences (2025) Vol. 12, Iss. 1, pp. 17-17
Open Access
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
Sushma Jadalannagari, Lorna Ewart
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 7, pp. 607-619
Open Access | Times Cited: 4
17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance
Ying Tian, Yuan Xie, Xinyu Hong, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29013-e29013
Open Access | Times Cited: 3
Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease
Jia‐Yi Zhang, Lingfang Wang, Meixiu Jiang
Medicine (2024) Vol. 103, Iss. 8, pp. e37185-e37185
Open Access | Times Cited: 2
Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry
Masamitsu Maekawa
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 6, pp. 1087-1105
Open Access | Times Cited: 2
Liver-specific actions of GH and IGF1 that protect against MASLD
Rhonda D. Kineman, Mercedes Del Rio-Moreno, David J. Waxman
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 1
Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations
Paresh P. Chothe, Vikram Arya, Bhagwat Prasad, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 12, pp. 1547-1550
Open Access | Times Cited: 3
Comparative Pharmacokinetic Study of Rhubarb Anthraquinones in Normal and Nonalcoholic Fatty Liver Disease Rats
Fang Zhang, Rui Wu, Yanfang Liu, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023)
Closed Access | Times Cited: 3
Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Karin Fehsel
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2294-2294
Open Access
Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?
Giovanni Tarantino, Mauro Cataldi, Vincenzo Citro
Frontiers in Microbiology (2024) Vol. 15
Open Access
Role of CYP2D6 polymorphisms in tramadol metabolism in a context of co-medications and overweight
Pierre‐Jean Ferron, Romain Pelletier, Julie Massart, et al.
Food and Chemical Toxicology (2024) Vol. 196, pp. 115192-115192
Open Access
Page 1

Scroll to top